INVESTIGATIONALPreclinical‑stage. Not approved by FDA.
INVESTIGATIONALUnder development. Not cleared by FDA.
Molecular Anywhere.
Detect. Identify. Decide.
Every year, millions of infections go undetected because molecular testing requires a lab that isn’t there. We built a sealed, palm-sized consumable that integrates extraction, amplification, and detection in one unit — powered by self-heating chemistry. No electricity. No instruments. No lab infrastructure.PCR-grade molecular results in 15–30 minutes, wherever a sample can be collected.
A result only changes a life when it arrives in time to act.
Molecular tests see what other tests miss — the genetic signature of a pathogen, early and specifically. But the answer only changes what happens next when it reaches the patient in time to treat, isolate, or contain. The closer molecular detection gets to the patient, the more outcomes improve.
WHAT A POINT-OF-NEED MOLECULAR TEST HAS TO BE
For a molecular test to reach the patient, it has to clear eight constraints at once.
Lab PCR is accurate but stays in the lab. Antigen reaches the patient but isn’t molecular. The missing test has to do both — every capability below has to be true at the same time, or the test never leaves the bench.
01PortableFits in a hand, a backpack, a clinic drawer.
02DisposableNo reusable instrument to clean, calibrate, or repair.
03Equipment-freeNo thermocycler, no centrifuge, no power.
04Simple to runMinutes of training, not days. Operable by non-technicians.
05ConnectedReads to a phone. Logs a digital, time-stamped result.
06ScalableSame architecture, reprogrammed in software — not retooled in hardware.
07AccuratePCR-grade molecular sensitivity and specificity, not antigen-grade detection.
08AffordablePriced to deploy, not priced to ration.
POINT-OF-NEED · WHEREVER THE PATIENT IS
Wherever the patient is, the result must follow.
A test only matters when the result reaches someone who can act on it — at home, at the counter, at the bedside, or in the field. The point of need is wherever the patient already is.
A complete molecular diagnostics platform, redesigned for anywhere.
One four-step architecture. Two deployment formats. Lab-quality results anywhere.
Every molecular test—regardless of setting—depends on four essential steps: design, capture, amplify, and read. Traditionally, each step requires separate instruments, specialized workflows, and trained operators inside a laboratory. We integrated all four into a single programmable architecture, enabling lab-quality testing in a user-friendly device or field-ready kit.
01
Design
BioSeeker AI-engineered primers & probes
02
Capture
~2 min extraction
03
Amplify
10–15 min
04
Read
5–10 min on the mLFA strip
DEPLOYMENT FORMATS
Two ways to deploy the platform.
Programmable for any DNA or RNA target — viral, bacterial, parasitic, and beyond. Reprogram the assay; the platform stays the same.
SAMPLE · TO · RESULT
15–30 min
From sample at the point of need to a digital, time-stamped molecular result.
FORMAT 01
SeekIt
Portable · connected · user friendly
Late-stage development.
FORMAT 02
Field Kit
Affordable · disposable · scalable
Ready to deploy
FORMAT 01 · DEVICE-BASED DEPLOYMENT
SeekIt
One disposable unit. One twist of a knob. One integrated device.
A palm-sized, sealed, infrastructure-free, single-use consumable that integrates extraction, amplification, and detection in one unit. No electricity. No instruments. No lab infrastructure. Self-heating chemistry runs the test. Add the sample. Twist the knob. Scan the strip. The SeekIt Mobile App reads the result with a phone camera and logs it digitally.
01
Connect the sample vial
Sample vial attaches to the device.
02
Twist the knob
Turning the knob routes the sample through each sealed chamber.
03
Extraction step
The integrated extraction chamber captures DNA or RNA from the sample and isolates waste in a separate compartment.
04
Amplification
The amplification chambers hold the sample at an elevated temperature using built-in self-heating chemistry.
05
mLFA detection
After the amplification step, the integrated mLFA strips activate automatically, revealing results for up to four targets at once.
06
Digital readout
Download the SeekIt Mobile app and use your phone camera to scan the strip and log a digital, time-stamped result.
15–25 minSample to result
Up to 4Targets per device
ZeroExternal instruments
FORMAT 02 · FIELD-CONFIGURABLE MOLECULAR FORMAT
Field Kit
The same molecular workflow in modular form. Built for biodefense, agricultural biosecurity, and field response.
The Field Kit is the SeekIt workflow in individual parts: a lysis tube, a Seek Extraction unit, a Seek Amplification pellet, and an mLFA strip. Infrastructure-free, single-use, consumable — no electricity, no instrument, no lab required.
01
Sample preparation
Sample is combined with lysis buffer in the lysis tube.
02
Seek Extraction
The extraction unit captures DNA/RNA on its binding membrane. No spin column, no centrifuge.
03
Seek Amplification
Extracted sample is added to the amplification tube containing the reaction pellet, where it then sits at room temperature to incubate.
04
mLFA strip detection
Test strip is placed into the amplification tube where the result line can be read directly on the strip after a few minutes.
20–30 minSample to result
ZeroOutside equipment
Ambient‑stableNo cold chain required.
A PROGRAMMABLE PLATFORM
One platform. Many tests.
Each technology is independently programmable. Change the chemistry, change the target — the architecture stays the same. That means a single platform can support many tests across labs, clinics, and the field.
LAB WORKFLOWS
Seek Extraction and Seek Amplification + BioSeeker can be deployed independently.
Seek Extraction is a stand-alone extraction chemistry. Seek Amplification, paired with BioSeeker-designed assays, is a stand-alone amplification + design workflow. Each can drop into existing lab pipelines — including PCR — without the rest of the stack.
Seek Extraction — extraction for any downstream molecular method.
Seek Amplification + BioSeeker — isothermal amplification with assays designed for any DNA or RNA target.
DISEASE-SPECIFIC TESTS
Hundreds of tests can be developed for SeekIt and the Field Kit.
Only the BioSeeker-designed primers and probes change — synthesized and built into each new consumable. The device, workflow, and all other materials stay the same. Every test inherits the same single-use, infrastructure-free workflow: sample in, strip out, in 15–30 minutes.
Viral, bacterial, parasitic — any DNA or RNA sequence.
Human health, agriculture, biosecurity — one architecture across scenarios.
Every new test is one BioSeeker-designed primer/probe set away. The platform scales with the pipeline.
THE TECHNOLOGIES
The science that makes molecular-anywhere possible.
TECHNOLOGY 01 · SEEK EXTRACTION
Removing the Bottleneck of DNA/RNA Extraction
What it isSeek Extraction (Velox™) is a gravity-driven process that releases and purifies DNA and RNA from a raw biological sample in under two minutes; no centrifuge, no spin column, no power required.
What it replacesCentrifuges, heat blocks, spin columns, lysis robots, and the training-dependent workflow that sample prep usually demands.
Why it mattersSample prep is the hidden bottleneck that keeps molecular testing dependent on lab equipment. Seek Extraction compresses the process into a sealed, field-ready step so any workflow — point-of-need, central lab, research, or high-throughput — starts faster and finishes cleaner.
< 2 minPer extraction
~8× faster16 samples in 35 min vs. 2–4 hrs lab protocol
Sample to purified eluate in under two minutes — no centrifuge, no power.
1
Collect & bind
Sample in vial 1. Screw onto Seek Extraction. Rotate: sample drains over the membrane and DNA/RNA bind. Rotate back: waste returns to vial 1.
2
Swap & elute
Remove vial 1. Screw on vial 2 (preloaded with elution buffer). Rotate: buffer drains over the membrane and releases the bound nucleic acids.
3
Collect eluate
Rotate back. Purified eluate collects in vial 2. Unscrew. Extraction is now complete and sample is ready to amplify.
FIELD-VALIDATED MATRICES
Seek Extraction, tested on the hardest samples and matrices first.
Seek Extraction has been validated across six matrices — tissue, whole blood, saliva, urine, respiratory UTM, and bacterial cultures. Yields are comparable to lab-grade column kits and roughly 8× faster for batch processing (16 samples in 35 min vs. 2–4 hours), with downstream compatibility for both qPCR and ANINA isothermal amplification.
Tissue
Hover to read
Tissue
Shrimp muscle & pleopod, mouse tissues. Dense and inhibitor-rich.
Lab-grade yield — 16 samples in 35 min, ~8× faster than column-based kits.
Blood
Hover to read
Blood
Whole blood, microneedle-collected. Hemoglobin and anticoagulants are classic inhibitors.
Clean qPCR & ANINA — gravity flow, no centrifuge.
Saliva
Hover to read
Saliva
Non-invasive, self-collectable. Mucus polysaccharides and viscosity choke columns.
Lab-grade EBV recovery validated across high-viscosity samples.
Urine
Hover to read
Urine
Non-invasive but rich in urea and salts that suppress amplification.
~10× higher DNA recovery vs. standard column-based kits. Validated on clinical gonorrhea-positive urine.
Swab (UTM)
Hover to read
Swab (UTM)
Nasal swabs in viral transport medium. Flu A/B, RSV, SARS-CoV-2 RNA — fragile and inhibitor-laden.
45–250× more copies recovered vs. untreated controls.
01 · SEEK EXTRACTION02 · ANINA
TECHNOLOGY 02 · SEEK AMPLIFICATION
Lab-grade amplification at ambient temperature — no thermocycler, no power.
What it isSeek Amplification (ANINA) is a new isothermal amplification chemistry that copies a target sequence billions of times in a single tube at ambient temperature — no thermocycler, no power.
What it replacesPCR thermocyclers, refrigerated reagents, and the lab workflow that surrounds them — without the trade-offs that have held other isothermal methods back.
Why it mattersAmplification is what makes a molecular test molecular. ANINA moves it out of the lab and into any workflow that needs PCR-grade answers.
One bead · one step
What ANINA Unlocks
20–45°CRuns at true ambient temperature — no thermocycler, no power.
15–30 minA PCR-grade answer in the time it takes to see a patient.
LyophilizedShelf-stable. No cold chain. Rehydrate and run.
PCR-gradeAmplification with a single pellet.
INSIDE THE REACTION
ANINA amplification
One pellet. Ambient temperature. Billions of tagged copies in 15–30 minutes.
1
Find the pathogen’s genetic sequence and copy it billions of times.
In order to detect the target pathogen, we have to find it and copy it exponentially.
2
The Annexing Probe latches onto a target sequence.
With the help of a DNA targeting enzyme (recombinase), the Annexing Probe invades the target sequence without any heat. The Annexing Probe includes a fluorescent tag (FAM) used for subsequent detection.
3
Primers attach to the target sequence.
Two primers bind on the top and bottom strands to mark the target region where amplification will take place. Primer 1 is short and sits next to the Annexing Probe, which is only possible because the Annexing Probe is already there to position it. This is the source of qPCR-grade specificity. Primer 2 is tagged with biotin for downstream detection.
4
Polymerase locates the two primers and builds a new strand.
Polymerase, a copying enzyme, builds a new copy of the target sequence.
5
The Annexing Probe detaches, finds a new target sequence, and starts the process again. Billions of times.
Each replication cycle takes seconds. In 15–30 minutes, a single target sequence becomes billions of FAM- and biotin-tagged copies from a single pellet, ready for detection.
02 · ANINA03 · BIOSEEKER
TECHNOLOGY 03 · BIOSEEKER
AI-powered assay design for rapid test development.
What it isA computational engine that scans a pathogen genome, locates the conserved target region, and designs a multiplex-ready primer–probe set in hours.
What it replacesWeeks of manual primer and probe design, expert curation, and the iterative wet-lab screening that follows.
Why it mattersBioSeeker is how new diagnostic assays come online fast. A new variant or pathogen can move into assay design in software, without rebuilding the underlying platform from scratch.
HoursFrom genome to candidate set
In silicoOff-target screened before lab
ProgrammableDesigned in software, built into the consumable
Nearly any pathogenViral, bacterial, parasitic
BioSeeker handles the layer between a pathogen genome and a manufacturable test.
DESIGN WORKFLOW
Primer and Probe Design In action
How a conserved target becomes a manufacturing-ready primer–probe set in software, in hours.
03 · BIOSEEKERREADOUT · mLFA
THE ENABLING LAYER
mLFA Detection
The simplicity of antigen. The accuracy of PCR.
Modified lateral flow strips deliver molecular results without any additional equipment. After ANINA copies the target, the Annexing Probe stays bound to the new strand, forming a tagged complex that flows across the paper strip and produces a visible line. No reader. No extra enzymes. No extra steps.
Sample pad
Gold marker
Test line (captures target)
Control line (confirms test worked)
MARKETS
Molecular without heat opens markets that have never had molecular before.
The same molecular diagnostic architecture powers applications in clinics, on farms, at a port of entry, or even for a forward-deployed unit.
Home
Hover to read
Home
Patients increasingly expect immediate answers for infectious diseases at home, before they travel for care.
Pharmacy
Hover to read
Pharmacy
Pharmacies are becoming front-line care access points. Testing supports rapid triage and enables pharmacists to guide treatment decisions (e.g., test-and-treat models for flu, COVID, strep).
Hospitals/Clinics
Hover to read
Hospitals/Clinics
Clinical decision-making depends on fast, accurate results. Delays from centralized labs can impact patient flow, infection control, and treatment decisions.
Veterinary & Aquaculture
Hover to read
Veterinary & Aquaculture
From veterinary clinics and farms to pond-side aquaculture operations — anywhere animals are raised, rapid molecular detection enables timely intervention that centralized labs cannot provide.
Defense
Hover to read
Defense
Military personnel, medics, and biosecurity or public health teams rely on applications for field environments, forward operating bases, and mobile labs. Rapid detection is critical for force health protection and operational readiness.
Field
Hover to read
Field
Remote outbreak response, border surveillance, and point-of-collection testing where no lab infrastructure exists and no cold chain can be maintained. The test comes to the sample.
The same architecture, reprogrammed at the sequence layer by BioSeeker for the targets each market cares about. The platform doesn’t change. The decision it unlocks does.
WHY EXISTING OPTIONS ARE INCOMPLETE
Most point-of-care testing still miniaturizes the lab. Seek removes its dependencies.
PCR is the gold standard, but it stays inside the lab. Rapid antigen reaches the field, but it lacks molecular sensitivity. Isothermal systems condensed the lab workflow, but they kept power and cold-chain dependencies. We built the missing fourth option: PCR-level performance, no instruments, no power, no cold chain.
Lab PCRCentralized · gold standard
Rapid antigenPoint-of-care · non-molecular
Isothermal POCCartridge molecular
SeekItPoint-of-need molecular.
Access
Dependent on centralized labs with delayed turnaround.
Anywhere a strip can be read. Trades molecular accuracy for reach.
Confined to clinics with reliable power and trained staff.
Wherever the patient or sample is. Clinic, farm, border, home.
Sensitivity
Molecular gold standard. Single-copy detection in a controlled lab setting.
Protein detection only. Misses low-titer and early-stage cases.
Molecular, but format-limited. Multiplexing and low-copy detection vary.
Molecular sensitivity in field conditions. Demonstrated low-copy detection in lab validation studies (internal data on file).
No instrument. No power. No cold chain. Shelf-stable cartridge.
Field-readiness
Never leaves the lab.
Portable, disposable, self-contained.
Decentralized, not deployable. Tied to a fixed reader and supply chain.
Built for the perimeter. Disposable, single-use, instrument-free.
Molecular accuracy. Antigen-level access. The missing fourth option, built for the field from the molecule up.
Partner with us
Four ways to put molecular-anywhere diagnostics to work. Tell us the disease, the operating environment, and the decision the test has to unlock — we’ll match an option to it.
01
Co-development
Bring us a target or clinical need. We engineer it onto SeekIt™ — BioSeeker-designed primers and probes, Seek Extraction tuned to your sample type, ANINA amplification, mLFA readout. A co-developed point-of-need test built on our chemistry stack instead of yours.
SeekIt™ is not currently available for open purchase. We are moving into the field through structured pilots with select public-health, defense, biosecurity, and animal-health partners.
For developers who want to plug Seek technology into an existing pipeline: BioSeeker + Seek Amplification (ANINA™) as an integrated AI-designed primer/probe and isothermal amplification pair, or Seek Extraction (Velox™) as a standalone field-deployable sample prep module.
Active across U.S. federal innovation networks and international collaborations in Australia and Vietnam. Open to sovereign health agencies, global health organizations, and international biosecurity and pandemic preparedness programs looking for field-deployable molecular diagnostic capability.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
